India plans incentives for diabetes, obesity drug makers
India will incentivise local GLP-1 drug manufacturing by 2026, targeting diabetes and obesity treatments, as Novo Nordisk's patent expires.
Increased miscarriage and stillbirth during extreme weather
The chance of a miscarriage or stillbirth can be up to 8% higher during floods or long periods of heat than in normal times.
Robotic surgery revolutionises public healthcare
In the beleaguered public health sector cutting-edge surgical robots have been used to perform more than 600 surgeries at two Cape Town public hospitals.
FDA unveils plan to boost diversity in clinical trials
The FDA's draft guidance aims to improve diversity in clinical trials by encouraging manufacturers to set enrolment goals based on age, ethnicity, sex, and race.
Obesity drugs show promise in combatting substance abuse
GLP-1 receptor agonists, initially for diabetes and weight loss, show promise in substance addiction treatment. A transformative breakthrough in healthcare.
SA activates plan to contain rising Mpox cases
The South African Border Management Authority has activated its Mpox preparedness plan, implementing robust screening at all ports of entry.